Ask me later

Ask me later

How likely are you to recommend Redeye to a friend or colleague?

1

2

3

4

5

6

7

8

9

10

Not likely

Very likely

Not likely

1

2

3

4

5

6

7

8

9

10

Very likely

Message received

Thanks again for rating us!

May 11 2021

07:00-08:30

Strategy Update: AlzeCure Pharma

Live events are available to Redeye members

Sign up for a free membership

Already a member?

Sign in

About event

Schedule

Event Videos

Updated

18:10

Participating

ALZECURE UPDATE ON PROGRESS IN THEIR PAINLESS PLATFORM

Welcome to a Redeye event where AlzeCure will give a presentation on its project platform Painless and the progress made, with recent positive clinical results from the ACD440 phase Ib trial for neuropathic pain and advancements made in the TrkA-NAM pain project, projects that complement AlzeCure’s broad Alzheimer’s portfolio.

Presenting will be Martin Jönsson, CEO, Märta Segerdahl, CMO, Pontus Forsell, Head of Discovery & Research and Johan Sandin, CSO. The event will include a Q&A session and discussion led by Anders Hedlund, analyst at Redeye.

 

This event will be presented in English

 

Sign up for this event

Location

Live stream at Redeye.se/events

Contact organizer

Add to google calendar